NCT01989533View on ClinicalTrials.gov

Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 19, 2013

Primary Completion Date

April 8, 2019

Study Completion Date

April 8, 2019

Conditions
Vaccine Response
Interventions
BIOLOGICAL

Ad4-mgag

Ad4 live virus vaccine with an HIV insert

BIOLOGICAL

Ad4-EnvC150

Ad4 live virus vaccine with an HIV insert

BIOLOGICAL

gp 120 Protein Boost

HIV protein boost

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Sponsors

Collaborators (1)

Emergent BioSolutions
All Listed Sponsors
collaborator

Emergent BioSolutions

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH